Cat FIP Antiviral Treatment Welfare Advance

Antiviral treatments for feline infectious peritonitis (FIP) represent one of the most significant recent advances in feline welfare, transforming a previously fatal disease into a treatable condition.

Key Facts

Feline infectious peritonitis (FIP) was historically considered universally fatal within weeks to months of diagnosis
Antiviral nucleoside analogues including GS-441524 achieve remission in approximately 85% of treated cats
GS-441524 was developed from remdesivir and specifically targets feline coronavirus replication
Treatment courses typically last 12 weeks and require daily medication or injection
Access to licensed GS-441524 treatments is still limited in some countries, with unregistered products filling gaps
Treatment costs remain high, creating welfare inequality between cats of owners with different financial means
Long-term follow-up data suggests sustained remission for many treated cats

Welfare Considerations

FIP antivirals represent a transformative welfare advance - a disease that meant inevitable death now has an 85%+ cure rate. Every cat that dies of untreated FIP in a world where treatment exists is a preventable welfare loss. Expanding access to affordable, licensed treatment and supporting veterinary awareness of updated treatment options is an urgent welfare priority.

What You Can Do

If your cat is diagnosed with FIP, consult a specialist vet about antiviral treatment options immediately
Support campaigns for licensed, affordable FIP antiviral access in countries where this is limited
Donate to feline health research organisations advancing antiviral treatment development
Share information about FIP antiviral treatments with cat owner networks
Advocate for pet insurance to cover FIP antiviral treatment costs